Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zeneng Wang

Showing results (81-90 of 148) with videos related to

Pageof 15
Sort By:
Bone|May 16, 2022
Trimethylamine N-oxide and hip fracture and bone mineral density in older adults: The cardiovascular health studyRachel E Elam, Petra Bůžková, Joshua I Barzilay, et al.
Journal of Lipid Research|November 8, 2014
Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosisDiana M Shih, Zeneng Wang, Richard Lee, et al.
JAMA Network Open|August 27, 2021
Association of Trimethylamine N-Oxide and Related Metabolites in Plasma and Incident Type 2 Diabetes: The Cardiovascular Health StudyRozenn N Lemaitre, Paul N Jensen, Zeneng Wang, et al.
Scientific Reports|January 13, 2021
Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in miceWenchao Zhang, Aika Miikeda, Jonathan Zuckerman, et al.
Metabolism: Clinical and Experimental|December 4, 2020
Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progressionNisreen Nimer, Ibrahim Choucair, Zeneng Wang, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 25, 2020
Small molecule inhibition of gut microbial choline trimethylamine lyase activity alters host cholesterol and bile acid metabolismPreeti Pathak, Robert N Helsley, Amanda L Brown, et al.
Hepatology Communications|October 11, 2023
Dysregulated meta-organismal metabolism of aromatic amino acids in alcohol-associated liver diseaseMarko Mrdjen, Emily Huang, Vai Pathak, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 10, 2019
Genetic Deficiency of Flavin-Containing Monooxygenase 3 ( Fmo3) Protects Against Thrombosis but Has Only a Minor Effect on Plasma Lipid Levels-Brief ReportDiana M Shih, Weifei Zhu, Rebecca C Schugar, et al.
Atherosclerosis|April 11, 2025
NAD<sup>+</sup> boosting increases atherosclerotic plaques and inflammation in Apoe knockout miceYu-Jen Wang, Daniel S Gaul, Era Gorica, et al.
Cell Metabolism|December 3, 2014
γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAORobert A Koeth, Bruce S Levison, Miranda K Culley, et al.
Pageof 15

Showing results (81-90 of 148) with videos related to

Sort By:
Pageof 15
Bone|May 16, 2022
Trimethylamine N-oxide and hip fracture and bone mineral density in older adults: The cardiovascular health studyRachel E Elam, Petra Bůžková, Joshua I Barzilay, et al.
Journal of Lipid Research|November 8, 2014
Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosisDiana M Shih, Zeneng Wang, Richard Lee, et al.
JAMA Network Open|August 27, 2021
Association of Trimethylamine N-Oxide and Related Metabolites in Plasma and Incident Type 2 Diabetes: The Cardiovascular Health StudyRozenn N Lemaitre, Paul N Jensen, Zeneng Wang, et al.
Scientific Reports|January 13, 2021
Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in miceWenchao Zhang, Aika Miikeda, Jonathan Zuckerman, et al.
Metabolism: Clinical and Experimental|December 4, 2020
Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progressionNisreen Nimer, Ibrahim Choucair, Zeneng Wang, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 25, 2020
Small molecule inhibition of gut microbial choline trimethylamine lyase activity alters host cholesterol and bile acid metabolismPreeti Pathak, Robert N Helsley, Amanda L Brown, et al.
Hepatology Communications|October 11, 2023
Dysregulated meta-organismal metabolism of aromatic amino acids in alcohol-associated liver diseaseMarko Mrdjen, Emily Huang, Vai Pathak, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 10, 2019
Genetic Deficiency of Flavin-Containing Monooxygenase 3 ( Fmo3) Protects Against Thrombosis but Has Only a Minor Effect on Plasma Lipid Levels-Brief ReportDiana M Shih, Weifei Zhu, Rebecca C Schugar, et al.
Atherosclerosis|April 11, 2025
NAD<sup>+</sup> boosting increases atherosclerotic plaques and inflammation in Apoe knockout miceYu-Jen Wang, Daniel S Gaul, Era Gorica, et al.
Cell Metabolism|December 3, 2014
γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAORobert A Koeth, Bruce S Levison, Miranda K Culley, et al.
Pageof 15